| For all SLN+ Pts (n = 285) | For pts with known angiolymphatic invasion status (n = 213) | For pts with known angiolymphatic invasion and ER status (n = 171) |
---|---|---|---|
RP-ROC with 10-fold cross validation | Â | Â | Â |
Sensitivity (%) | Â | 78.8 | 83.2 |
Specificity (%) | Â | 75.5 | 78.1 |
Diagnostic Accuracy by AUC (%) | Â | 76.7 | 80.2 |
Boosted CART with 10-fold cross validation | Â | Â | Â |
Sensitivity (%) | 78.2 | 87.9 | 89.0 |
Specificity (%) | 62.0 | 71.4 | 74.7 |
Diagnostic Accuracy by AUC (%) | 67.7 | 77.5 | 80.3 |
Multivariable logistic regression with 10-fold cross validation | Â | Â | Â |
Sensitivity (%) | Â | 78.0 | 78.9 |
Specificity (%) | Â | 86.2 | 88.3 |
Diagnostic Accuracy by AUC (%) | Â | 83.3 | 84.9 |
MSKCC Breast Cancer Nomogram a | Â | Â | Â |
Diagnsotic Accuracy by AUC (%) | Â | Â | 76.7 |